Martina Pavlicová

Brandeis University

H指数:36

被引数:6,085

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamical Regulation of Blood Pressure and Cognitive Function

血压和认知功能的动态调节

AMERICAN JOURNAL OF HYPERTENSION

IF3.1

2025-09-010

PRE

Suicidal ideation in adults with opioid use disorder treated with buprenorphine-naloxone versus extended-release naltrexone

阿片类药物使用障碍成人患者中，接受丁丙诺啡-纳洛酮治疗与接受长效纳曲酮治疗者的自杀观念比较

american journal of drug and alcohol abuse

IF0

2025-07-110

PRE

A pilot study of disulfiram for individuals with persistent symptoms despite prior antibiotic treatment for Lyme disease

一项关于二硫化二乙基用于既往接受过莱姆病抗生素治疗但症状持续存在的个体的研究

FRONTIERS IN MEDICINE

IF3

2025-04-020

Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial

随机分配丁丙诺啡或纳曲酮治疗OUD对大麻使用结果的影响: X:BOT试验的二次分析

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-03-010

PRE

Proposed research classification criteria for Lyme disease in infection associated chronic illness studies

FRONTIERS IN MEDICINE

IF3

2025-02-250

OAAI

A Comparison of Neuropsychological Functioning between Patients With Opioid Use Disorders on Extended-Release Naltrexone and Buprenorphine

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-02-010

PRE

Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Substance Use Screening Rates and Screening Results Among Adult Primary Care Patients With Mental Health Conditions and Substance UseRelated Medical Conditions

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Patient Characteristics Associated With Retention on XR-NTX in the CTN-0051 Trial

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Cardiovascular variability, sociodemographics, and biomarkers of disease: the MIDUS study

FRONTIERS IN PHYSIOLOGY

IF3.4

2023-08-242

OAAI

Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder

JOURNAL OF ADDICTION MEDICINE

IF3.2

2023-05-172

Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT

JOURNAL OF ADDICTION MEDICINE

IF3.2

2023-01-051

PRE

Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes

阿片类药物使用障碍的药物治疗前和治疗期间的多物质使用: 患病率及其与治疗结果的关联

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2022-12-0112

OAAI

Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2022-07-015

OAAI

Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse (vol 131, 108447, 2021)

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2022-05-011

OAAI

Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis

用于临床预后癌症亚型和个性化治疗的多组学亚型: 系统回顾和荟萃分析

GENETICS IN MEDICINE

IF6.2

2022-01-016

PRE

Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD

X中基线和治疗相关的疼痛: 缓释纳曲酮与丁丙诺啡-纳洛酮对OUD的BOT比较效果研究

ADDICTION BIOLOGY

IF2.6

2021-12-072

PREAI

Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2021-12-0120

OAAI

Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial

在接受阿片类药物使用障碍治疗的门诊患者中，缓释纳曲酮在减少饮酒方面是否优于丁丙诺啡-纳洛酮？对CTN X:BOT试验的二次分析

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2021-11-232

Differential Treatment Response Between Hypochondriasis With and Without Prominent Somatic Symptoms

FRONTIERS IN PSYCHIATRY

IF3.2

2021-11-084

OAAI

Martina Pavlicová

个人简介

教育背景

工作经历

荣誉奖项

研究方向